Suppr超能文献

子宫肌瘤生长研究:治疗干预的决定因素

The fibroid growth study: determinants of therapeutic intervention.

作者信息

Davis Barbara J, Haneke Karen E, Miner Kelly, Kowalik Ania, Barrett J Carl, Peddada Shyamal, Baird Donna Day

机构信息

National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.

出版信息

J Womens Health (Larchmt). 2009 May;18(5):725-32. doi: 10.1089/jwh.2008.0903.

Abstract

AIMS

The demographics, ethnicity, symptoms, lifestyle characteristics, and treatment outcomes are analyzed in participants of a study designed to evaluate uterine leiomyoma growth and correlate symptoms and outcomes in a clinically relevant population of women (Fibroid Growth Study).

METHODS

Women included in the Fibroid Growth Study (FGS) completed a medical history and physical examination, underwent T1-weighted and T2-weighted magnetic resonance image (MRI) scans, provided urine and blood samples at each scheduled MRI, and responded to an initial extensive telephone-administered questionnaire followed by abbreviated monthly questionnaire updates. Summary scores were developed to quantify stress, pain, and bleeding. The Wilcoxin test was used for statistical comparisons between study participant characteristics and tumor-related characteristics.

RESULTS

Participants included 116 premenopausal women, ranging in age from 20 to 54 years; 48% were black women, 41% were white women, 10% were women of other or multiple racial backgrounds, and 1% did not self-identify. Over 90% of participants had multiple leiomyomas, and nearly a third had more than 10. Black women were younger and had more fibroids, but no differences were found in the proportions of black and white women choosing an intervention; 44% of black women and 40% of white women chose intervention during the study.

CONCLUSIONS

There was no correlation between number of leiomyomas or uterine size and choosing treatment. However, women who opted for treatment were more symptomatic, with higher bleeding and pain scores, compared with the women with no intervention. Consequently, our study suggests that once women are symptomatic, black and white women choose surgery as a treatment method for the same reasons and at about the same rates. Moreover, our data suggest that bleeding and pain, not the size or multiplicity of fibroids, determine the choice for intervention. Therefore, aggressive management of pain and bleeding may be effective in reducing the need for surgical intervention.

摘要

目的

在一项旨在评估子宫平滑肌瘤生长情况并关联症状与结局的临床相关女性人群研究(肌瘤生长研究)的参与者中,分析其人口统计学特征、种族、症状、生活方式特点及治疗结局。

方法

纳入肌瘤生长研究(FGS)的女性完成病史采集和体格检查,接受T1加权和T2加权磁共振成像(MRI)扫描,在每次预定的MRI检查时提供尿液和血液样本,并回答一份初始的广泛电话调查问卷,随后每月进行简短问卷更新。制定了汇总评分以量化压力、疼痛和出血情况。采用Wilcoxin检验对研究参与者特征与肿瘤相关特征进行统计学比较。

结果

参与者包括116名绝经前女性,年龄在20至54岁之间;48%为黑人女性,41%为白人女性,10%为其他或多种种族背景的女性,1%未表明自己的种族。超过90%的参与者有多个平滑肌瘤,近三分之一的参与者有10个以上。黑人女性更年轻且肌瘤更多,但在选择干预措施的黑人女性和白人女性比例上未发现差异;44%的黑人女性和40%的白人女性在研究期间选择了干预措施。

结论

平滑肌瘤数量或子宫大小与选择治疗之间无相关性。然而,与未接受干预的女性相比,选择治疗的女性症状更明显,出血和疼痛评分更高。因此,我们的研究表明,一旦女性出现症状,黑人和白人女性选择手术作为治疗方法的原因相同且比例相近。此外,我们的数据表明,出血和疼痛而非肌瘤的大小或数量决定了干预的选择。因此,积极处理疼痛和出血可能有效减少手术干预的需求。

相似文献

1
The fibroid growth study: determinants of therapeutic intervention.
J Womens Health (Larchmt). 2009 May;18(5):725-32. doi: 10.1089/jwh.2008.0903.
2
The management of uterine leiomyomas.
J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8.
3
The management of uterine leiomyomas.
J Obstet Gynaecol Can. 2003 May;25(5):396-418; quiz 419-22.
4
Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
Acta Obstet Gynecol Scand. 2016 Sep;95(9):984-90. doi: 10.1111/aogs.12930. Epub 2016 Jun 7.
5
Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms.
Hum Reprod. 2014 Mar;29(3):490-501. doi: 10.1093/humrep/det459. Epub 2014 Jan 15.
7
Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study.
Am J Obstet Gynecol. 2016 Dec;215(6):750.e1-750.e8. doi: 10.1016/j.ajog.2016.06.036. Epub 2016 Jun 28.
9
EMAS position statement: management of uterine fibroids.
Maturitas. 2014 Sep;79(1):106-16. doi: 10.1016/j.maturitas.2014.06.002. Epub 2014 Jun 9.
10
A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.
Am J Obstet Gynecol. 2018 Dec;219(6):591.e1-591.e8. doi: 10.1016/j.ajog.2018.09.039. Epub 2018 Oct 3.

引用本文的文献

1
Sonographic Monitoring of Growth of Uterine Myomas in Untreated Women and Respective Influence Factors.
Geburtshilfe Frauenheilkd. 2023 Apr 5;83(4):446-452. doi: 10.1055/a-1996-2980. eCollection 2023 Apr.
2
Massive Leiomyomatous Uterine Proliferation Following Kidney Transplantation: A Case Report and Literature Review.
Case Rep Transplant. 2018 Nov 28;2018:3874937. doi: 10.1155/2018/3874937. eCollection 2018.
4
Epidemiology of Uterine Fibroids: From Menarche to Menopause.
Clin Obstet Gynecol. 2016 Mar;59(1):2-24. doi: 10.1097/GRF.0000000000000164.
5
Role of vitamin D in uterine fibroid biology.
Fertil Steril. 2015 Sep;104(3):698-706. doi: 10.1016/j.fertnstert.2015.05.031. Epub 2015 Jun 13.
6
Use of medical, surgical and complementary treatments among women with fibroids.
Eur J Obstet Gynecol Reprod Biol. 2014 Nov;182:220-5. doi: 10.1016/j.ejogrb.2014.09.004. Epub 2014 Sep 16.
7
Natural Size Development of Myomata - Ultrasound Observational Study of 55 Premenopausal Patients.
Geburtshilfe Frauenheilkd. 2014 Jan;74(1):75-80. doi: 10.1055/s-0033-1351072. Epub 2014 Jan 21.
10
Short-term change in growth of uterine leiomyoma: tumor growth spurts.
Fertil Steril. 2011 Jan;95(1):242-6. doi: 10.1016/j.fertnstert.2010.05.011. Epub 2010 Jun 17.

本文引用的文献

1
Health care resource use for uterine fibroid tumors in the United States.
Am J Obstet Gynecol. 2006 Oct;195(4):955-64. doi: 10.1016/j.ajog.2006.02.020. Epub 2006 May 24.
2
High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.
Am J Obstet Gynecol. 2003 Jan;188(1):100-7. doi: 10.1067/mob.2003.99.
3
Uterine fibroids.
Lancet. 2001 Jan 27;357(9252):293-8. doi: 10.1016/S0140-6736(00)03622-9.
4
Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.
Obstet Gynecol. 1997 Dec;90(6):967-73. doi: 10.1016/s0029-7844(97)00534-6.
5
Uterine myomas and factors associated with hysterectomy in premenopausal women.
Am J Obstet Gynecol. 1997 Jun;176(6):1213-7; discussion 1217-9. doi: 10.1016/s0002-9378(97)70337-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验